| Dr Renee E Riddle, MD | |
|
206 S 6th Ave, West Reading, PA 19611-1411 | |
| (484) 628-5437 | |
| Not Available |
| Full Name | Dr Renee E Riddle |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 206 S 6th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093780231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D59067 (Maryland) | Primary |
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Entity Name | Reading Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992387518 PECOS PAC ID: 7618886490 Enrollment ID: O20040408001076 |
News Archive
New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Entity Name | Phoenixville Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891866182 PECOS PAC ID: 5799796850 Enrollment ID: O20060606000128 |
News Archive
New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Renee E Riddle, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0799 | Dr Renee E Riddle, MD 206 S 6th Ave, West Reading, PA 19611-1411 Ph: (484) 628-5437 |
News Archive
New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
Saroj Parida, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6th Ave & Spruce St, West Reading, PA 19611 Phone: 610-988-8843 | |
Olubunmi K. Ojikutu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 206 S 6th Ave, West Reading, PA 19611 Phone: 610-988-5437 Fax: 610-988-5438 | |
Gerard Brown, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6th Ave & Spruce St, West Reading, PA 19611 Phone: 610-988-8843 | |
Nina Niamkey Duke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 7th Ave, Suite 3170, West Reading, PA 19611 Phone: 610-898-9380 Fax: 610-478-1170 | |
Lorie Radecki Ulmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 7th Ave, Ste 3170, West Reading, PA 19611 Phone: 610-374-4491 Fax: 610-478-1170 | |
Dr. Anna N/a Karasik, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 655 Walnut St, West Reading, PA 19611 Phone: 610-972-9222 Fax: 610-372-0232 |